Skip to content

Positive Emotions After Acute Coronary Events at Northwestern University

Positive Psychology for Acute Coronary Syndrome Patients: A proof-of Concept Feasibility Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04062383
Acronym
PEACE-NU
Enrollment
1
Registered
2019-08-20
Start date
2020-02-24
Completion date
2020-03-13
Last updated
2022-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACS - Acute Coronary Syndrome

Keywords

ACS, Positive Psychology, Motivational Interviewing, Positive emotions

Brief summary

This study is a single-arm, 12-week trial to test the feasibility of a PP-MI intervention for patients recently admitted following ACS. PP-MI is a novel positive psychology-based health behavior intervention that is adapted for patients hospitalized for ACS. The intervention aims to cultivate positive emotions in this vulnerable population that could provide broad and significant health benefits, and may have distinct-and more powerful-effects than simply attempting to dampen negative emotions. The primary aim is to assess whether the intervention exercises are feasible and linked with immediate boosts in positive affect upon completion. The secondary goal is to provide the research team with greater experience recruiting inpatients with an ACS, successfully completing intervention sessions, and administering psychological and medical assessments by phone.

Detailed description

The initial study visit will occur in-person two weeks after discharge from the hospital. Participants will meet with a member of the study staff (the study trainer) and complete self-report questionnaires assessing health behavior adherence and mental and physical health. Then, a study interventionist will provide a treatment manual for the positive psychology + motivational interviewing intervention, review the rationale for the initial exercise, and assign the first exercise. If the participant is in the positive psychology + motivational interviewing condition, the trainer will explain the rationale for both the positive psychology and goal-setting and motivational interviewing portions of the program, and will be assigned the first exercise. Participants will then be given an accelerometer, which they will be asked to wear for 7 days to ensure that they are comfortable with the device and that useable data can be obtained from the participant. Participants will then complete twelve 30-minute weekly phone sessions with a study trainer. The phone sessions primarily will include a review of the prior week's session content and a discussion of the rationale and assignment of the next week's exercise/assignment. Upon the completion of these calls, a blinded member of the study staff will call participants to administer self-report outcome measures. Participants will also be asked to wear an accelerometer at the follow-up timepoint as an objective measure of physical activity, which they will return by mail to the study staff.

Interventions

For the positive psychology portion of the intervention, the study trainer will (a) review the week's positive psychology exercise, (b) discuss the rationale of the next week's positive psychology exercise through a guided review of the positive psychology manual, and (c) assign the next week's positive psychology exercise. For the motivational interviewing portion, participants will (a) review their physical activity goal from the prior week, (b) discuss techniques for improving physical activity, and (c) set a physical activity goal for the next week. Study trainers will use motivational interviewing techniques to facilitate goal setting.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eligible patients must meet at least two of three World Health Organization criteria for an acute MI: typical chest pain, elevated cardiac enzymes, and electrocardiographic changes consistent with MI. For UA, participants must have new-onset angina within 2 months, exacerbation of previous angina with rest or with minimal exercise, or angina within 2 weeks of MI. * Suboptimal adherence to health behaviors: eligible patients must meet a total item score of \<15 (suboptimal) based on three Medical Outcomes Study-Specific Adherence Scale (MOS SAS) items OR a total item score of 15 and a physical activity item score of \<5.

Exclusion criteria

* Cognitive deficits, assessed via a 6-item cognitive screen,33 used to assess appropriate participation of medically ill patients in research studies and defined by a score of \< 4. * Medical conditions precluding interviews or likely to lead to death within 6 months, determined in consultation with the primary treatment team and Dr. James Flaherty. * Individuals who have undergone coronary artery bypass surgery, or any open heart surgery, in the past 1 year. * Inability to perform moderate to vigorous physical activity, as defined by an inability to walk without aid of an assistive device such as a walker or cane, OR inability to walk at a steady pace for at least 5 minutes without stopping. * Inability to communicate in English.

Design outcomes

Primary

MeasureTime frameDescription
Number of intervention sessions completed by participants12 weeksMeasured by number of intervention sessions completed by participants

Secondary

MeasureTime frameDescription
Change in medication adherenceBaseline, 12 weekMeasured by SRMA, a two-item self-report medication adherence scale measuring percentage of time patients report taking their heart medications in the past one and two weeks.
Change in dietary adherenceBaseline, 12 weekMeasured by the MEDFICTS scale, a National Cholesterol Education Program-developed scale inquiring about saturated fat.
Change in positive affectBaseline, 12 weekMeasured by the Positive and Negative Affect Schedule (PANAS)
Change in trait optimismBaseline, 12 weekMeasured by the Life Orientation Test-Revised (LOT-R)
Change in state optimismBaseline, 12 weekMeasured by the State Optimism Scale developed by Dr. Jeff Huffman
Change in anxietyBaseline, 12 weekMeasured by the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A)
Change in physical activityBaseline, 12 weekAs measured by accelerometer
Change in physical functionBaseline, 12 weekMeasured by the Duke Activity Status Index (DASI)
Change in health-related quality of lifeBaseline, 12 weekMeasured by the Short Form 12 (SF-12)
Change in adherence to health behaviorsBaseline, 12 weekMeasured by the three items from the Medical Outcomes Study-Specific Adherence Scale (MOS SAS)
Change in cardiac symptomsBaseline, 12 weekMeasured by a checklist taken from the Women and Ischemia Syndrome Evaluation Study
Change in perceived stressBaseline, 12 weekMeasured by the perceived stress scale (PSS-4) measure
Change in depressionBaseline, 12 weekMeasured by the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026